Showing results (1671-1680 of 1,927) with videos related to

Sort By:
Pageof 193
Movement Disorders : Official Journal of the Movement Disorder Society|May 20, 2009
Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic studyMaria C Rodriguez-Oroz, Pablo Martínez Lage, Jose Sanchez-Mut, et al.
Clinical Genetics|April 4, 2017
Study of the Huntington's disease IT-15 gene in different ethnic groups in EcuadorC Paz-Y-Miño, C Salazar-Ruales, J M García-Cárdenas, et al.
Molecular & Cellular Proteomics : MCP|October 20, 2012
A bioinformatics approach for integrated transcriptomic and proteomic comparative analyses of model and non-sequenced anopheline vectors of human malaria parasitesCeereena Ubaida Mohien, David R Colquhoun, Derrick K Mathias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2011
Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 studyM Martín, P Sánchez-Rovira, M Muñoz, et al.
Plos One|September 28, 2017
Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-BMiriam Rosás-Umbert, Beatriz Mothe, Marc Noguera-Julian, et al.
AIDS Research and Human Retroviruses|February 15, 2001
The molecular epidemiology of HIV type 1 of men in MexicoL G Rivera-Morales, V A Novitsky, J R Trujillo, et al.
Neurologia (Barcelona, Spain)|May 14, 2005
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination]A Castro, F Valldeoriola, G Linazasoro, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|July 22, 2014
Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse modelsMaribel G Vallespí, Gilmara Pimentel, Ania Cabrales-Rico, et al.
QJM : Monthly Journal of the Association of Physicians|June 23, 2020
Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled studyG Rojas-Marte, M Khalid, O Mukhtar, et al.
Pageof 193